drugset / Trial / NCT00547183

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

NCT00547183

Phase 3 Completed 298 enrolled Eli Lilly and Company ICOS Corporation · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Study to evaluate the safety and effectiveness of 2.5 mg and 5 mg tadalafil when taken by men with diabetes mellitus who have problems getting and maintaining an erection.

Timeline

Start
2004-10
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 2.5 mg Oral
Comparator Tadalafil Small molecule 5 mg Oral

Indications